Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 630198, 19 pages
http://dx.doi.org/10.1155/2013/630198
Research Article

Inhibitory Effects of Traditional Herbal Formula Pyungwi-San on Inflammatory Response In Vitro and In Vivo

1Division of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan 626-870, Republic of Korea
2College of Oriental Medicine, Daegu Haany University, Gyeongsan 712-715, Republic of Korea
3Department of Pharmaceutical Engineering, Daegu Haany University, Gyeongsan 712-715, Republic of Korea
4Institute of Marine BioTechnology, Pusan National University, Busan 609-735, Republic of Korea

Received 19 September 2012; Accepted 7 January 2013

Academic Editor: Arndt Büssing

Copyright © 2013 Ji Young Cha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Guzik, R. Korbut, and T. Adamek-Guzik, “Nitric oxide and superoxide in inflammation and immune regulation,” Journal of Physiology and Pharmacology, vol. 54, no. 4, pp. 469–487, 2003. View at Google Scholar · View at Scopus
  2. T. Lawrence, D. A. Willoughby, and D. W. Gilroy, “Anti-inflammatory lipid mediators and insights into the resolution of inflammation,” Nature Reviews Immunology, vol. 2, no. 10, pp. 787–795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Y. Park, M. H. Pillinger, and S. B. Abramson, “Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases,” Clinical Immunology, vol. 119, no. 3, pp. 229–240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Blobaum and L. J. Marnett, “Structural and functional basis of cyclooxygenase inhibition,” Journal of Medicinal Chemistry, vol. 50, no. 7, pp. 1425–1441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Nathan, “Nitric oxide as a secretory product of mammalian cells,” The FASEB Journal, vol. 6, no. 12, pp. 3051–3064, 1992. View at Google Scholar · View at Scopus
  6. J. MacMicking, Q. W. Xie, and C. Nathan, “Nitric oxide and macrophage function,” Annual Review of Immunology, vol. 15, pp. 323–350, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Nagy, J. M. Clark, E. I. Buzás, C. L. Gorman, and A. P. Cope, “Nitric oxide, chronic inflammation and autoimmunity,” Immunology Letters, vol. 111, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar
  8. A. K. Lee, S. H. Sung, Y. C. Kim, and S. G. Kim, “Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C/EBP and AP-1 activation,” British Journal of Pharmacology, vol. 139, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ghosh and M. Ksarin, “Missing pieces in the NF-κB puzzle,” Cell, vol. 109, pp. S81–S96, 2002. View at Publisher · View at Google Scholar
  10. E. D. Chan and D. W. H. Riches, “IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line,” American Journal of Physiology, vol. 280, no. 3, pp. C441–C450, 2001. View at Google Scholar · View at Scopus
  11. H. Jijon, B. Allard, and C. Jobin, “NF-κB inducing kinase activates NF-κB transcriptional activity independently of IκB kinase γ through a p38 MAPK-dependent RelA phosphorylation pathway,” Cellular Signalling, vol. 16, no. 9, pp. 1023–1032, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Olson, M. N. Hedrick, H. Izadi, T. C. Bates, E. R. Olivera, and J. Anguita, “p38 mitogen-activated protein kinase controls NF-κB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens,” Infection and Immunity, vol. 75, no. 1, pp. 270–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. W. Lee, S. C. Kim, T. W. Kwak et al., “Anti-Inflammatory Effects of Bangpungtongsung-San, a Traditional Herbal Prescription,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 892943, 12 pages, 2012. View at Publisher · View at Google Scholar
  14. A. Yoshimura, “Signal transduction of inflammatory cytokines and tumor development,” Cancer Science, vol. 97, pp. 439–447, 2006. View at Publisher · View at Google Scholar
  15. T. Kishimoto, S. Akira, M. Narazaki, and T. Taga, “Interleukin-6 family of cytokines and gp130,” Blood, vol. 86, no. 4, pp. 1243–1254, 1995. View at Google Scholar · View at Scopus
  16. B. Beutler and A. Cerami, “The biology of cachectin/TNF—a primary mediator of the host response,” Annual Review of Immunology, vol. 7, pp. 625–655, 1989. View at Google Scholar · View at Scopus
  17. C. R. Tonussi and S. H. Ferreira, “Tumour necrosis factor-α mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints,” Pain, vol. 82, no. 1, pp. 81–87, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. K. J. Yun, D. J. Koh, S. H. Kim et al., “Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-κB inactivation,” Journal of Agricultural and Food Chemistry, vol. 56, no. 21, pp. 10265–10272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Scheid, D. Bensky, A. Ellis, and R. Barolet, Chinese Herbal Medicine Formulas & Strategies, Eastland Press, Seattle, Wash, USA, 2009.
  20. J. E. Riedlinger, P. W. Tan, and W. Lu, “Ping wei san, a Chinese medicine for gastrointestinal disorders,” Annals of Pharmacotherapy, vol. 35, no. 2, pp. 228–235, 2001. View at Google Scholar · View at Scopus
  21. I. S. Shin, C. S. Seo, H. K. Ha et al., “Genotoxicity assessment of Pyungwi-san (PWS), a traditional herbal prescription,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 696–703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. H. S. Yi and J. Y. Moon, “Scavenging property of pyungwi-san herbal-acupuncture solution on ROS and RNS,” Korean Journal of Oriental Physiology and Pathology, vol. 21, pp. 165–170, 2007. View at Google Scholar
  23. C. S. Seo, J. A. Lee, D. Jung et al., “Simultaneous determination of liquiritin, hesperidin, and glycyrrhizin by HPLC-photodiode array detection and the anti-inflammatory effect of Pyungwi-san,” Archives of Pharmacal Research, vol. 34, no. 2, pp. 203–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. T. Cruz, C. B. Duarte, M. Gonçalo, A. Figueiredo, A. P. Carvalho, and M. C. Lopes, “Granulocyte-macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line,” Immunology and Cell Biology, vol. 79, no. 6, pp. 590–596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Higuchi, N. Higashi, H. Taki, and T. Osawa, “Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages,” Journal of Immunology, vol. 144, no. 4, pp. 1425–1431, 1990. View at Google Scholar · View at Scopus
  26. M. G. Rittig, A. Kaufmann, A. Robins et al., “Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes,” Journal of Leukocyte Biology, vol. 74, no. 6, pp. 1045–1055, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Reader, D. Holt, and A. Fulton, “Prostaglandin E2 EP receptors as therapeutic targets in breast cancer,” Cancer Metastasis Reviews, vol. 30, pp. 449–463, 2011. View at Publisher · View at Google Scholar
  28. J. Zhang and S. Rivest, “Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide,” Journal of Neurochemistry, vol. 76, no. 3, pp. 855–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nakatani, M. Atsumi, T. Arakawa et al., “Inhibitions of histamine release and prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant,” Biological and Pharmaceutical Bulletin, vol. 25, no. 9, pp. 1137–1141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Jung, J. H. Kim, S. J. Park, D. H. Kweon, S. H. Kim, and S. G. Ko, “Inhibitory effect of Agrimonia pilosa Ledeb. on inflammation by suppression of iNOS and ROS production,” Immunological Investigations, vol. 39, no. 2, pp. 159–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. M. El-Din, A. M. Senbel, A. A. Bistawroos et al., “A Novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug,” Basic and Clinical Pharmacology and Toxicology, vol. 108, no. 4, pp. 263–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. L. A. Tomé, L. Yu, I. De Castro, S. B. Campos, and A. C. Seguro, “Beneficial and harmful effects of L-arginine on renal ischaemia,” Nephrology Dialysis Transplantation, vol. 14, no. 5, pp. 1139–1145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. A. V. Delgado, A. T. McManus, and J. P. Chambers, “Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P,” Neuropeptides, vol. 37, no. 6, pp. 355–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. B. Aggarwal, “Nuclear factor-κB: the enemy within,” Cancer Cell, vol. 6, no. 3, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. S. K. Hansen, P. A. Baeuerle, and F. Blasi, “Purification, reconstitution, and IκB association of the c-Rel-p65 (RelA) complex, a strong activator of transcription,” Molecular and Cellular Biology, vol. 14, no. 4, pp. 2593–2603, 1994. View at Google Scholar · View at Scopus
  36. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Google Scholar · View at Scopus
  38. S. G. Kim, H. J. Kim, S. H. Choi, and J. Y. Ryu, “Inhibition of lipopolysaccharide-induced I-κB degradation and tumor necrosis factor-α expression by dimethyl-4,4'-dimethoxy-5,6,5',6'- dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB): minor role in hepatic detoxifying enzyme expression,” Liver, vol. 20, no. 4, pp. 319–329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. W. Kim, R. J. Zhao, S. J. Park et al., “Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production,” British Journal of Pharmacology, vol. 154, no. 1, pp. 165–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Guha and N. Mackman, “LPS induction of gene expression in human monocytes,” Cellular Signalling, vol. 13, no. 2, pp. 85–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Y. Xiao, W. X. Zhou, Y. X. Zhang et al., “Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-κB, p38, and JNK activation,” Immunology Letters, vol. 114, no. 2, pp. 81–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. S. Choi, S. H. Lee, H. S. Cho et al., “Inhibitory effect of obovatol on nitric oxide production and activation of NF-κB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells,” European Journal of Pharmacology, vol. 556, no. 1–3, pp. 181–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. J. Ajizian, B. K. English, and E. A. Meals, “Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ,” Journal of Infectious Diseases, vol. 179, no. 4, pp. 939–944, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Uto, M. Fujii, and D. X. Hou, “6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages,” Biochemical Pharmacology, vol. 70, no. 8, pp. 1211–1221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. W. V. Berghe, S. Plaisance, E. Boone et al., “p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor,” The Journal of Biological Chemistry, vol. 273, no. 6, pp. 3285–3290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. D. A. Gamache, J. T. Povlischock, and E. F. Ellis, “Carrageenan-induced brain inflammation. Characterization of the model,” Journal of Neurosurgery, vol. 65, no. 5, pp. 679–685, 1986. View at Google Scholar · View at Scopus
  47. R. L. C. Handy and P. K. Moore, “A comparison of the effects of L-NAME, 7-NI and L-NIL on caurageenan-induced hindpaw oedema and NOS activity,” British Journal of Pharmacology, vol. 123, no. 6, pp. 1119–1126, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Dawson, A. D. Sedgwick, J. C. W. Edwards, and P. Lees, “A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse,” International Journal of Tissue Reactions, vol. 13, no. 4, pp. 171–185, 1991. View at Google Scholar · View at Scopus
  49. J. H. Lee, Y. H. Choi, and B. T. Choi, “The anti-inflammatory effects of 2 Hz electroacupuncture with different intensities on acute carrageenan-induced inflammation in the rat paw,” International Journal of Molecular Medicine, vol. 16, no. 1, pp. 99–102, 2005. View at Google Scholar · View at Scopus
  50. M. Gupta, U. K. Mazumder, P. Gomathi, and V. T. Selvan, “Antiinflammatory evaluation of leaves of Plumeria acuminata,” BMC Complementary and Alternative Medicine, vol. 6, article 36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. C. V. Rao, A. R. Verma, P. K. Gupta, and M. Vijayakumar, “Anti-inflammatory and anti-nociceptive activities of Fumaria indica whole plant extract in experimental animals,” Acta Pharmaceutica, vol. 57, no. 4, pp. 491–498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Omote, K. Hazama, T. Kawamata et al., “Peripheral nitric oxide in carrageenan-induced inflammation,” Brain Research, vol. 912, no. 2, pp. 171–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Seibert, Y. Zhang, K. Leahy et al., “Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 12013–12017, 1994. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Q. Cunha, S. Poole, B. B. Lorenzetti, and S. H. Ferreira, “The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia,” British Journal of Pharmacology, vol. 107, no. 3, pp. 660–664, 1992. View at Google Scholar · View at Scopus
  55. S. Holt, F. Comelli, B. Costa, and C. J. Fowler, “Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors,” British Journal of Pharmacology, vol. 146, no. 3, pp. 467–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Liu, W. Zhang, L. Zhou, X. Wang, and Q. Lian, “Anti-inflammatory effect and mechanism of osthole in rats,” Journal of Chinese Medicinal Materials, vol. 28, no. 11, pp. 1002–1006, 2005. View at Google Scholar · View at Scopus
  57. H. Beloeil, Z. Ababneh, R. Chung, D. Zurakowski, R. V. Mulkern, and C. B. Berde, “Effects of bupivacaine and tetrodotoxin on carrageenan-induced hind paw inflammation in rats (part 1): hyperalgesia, edema, and systemic cytokines,” Anesthesiology, vol. 105, no. 1, pp. 128–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. S. T. Holgate, “The role of mast cells and basophils in inflammation,” Clinical and Experimental Allergy, Supplement, vol. 30, no. 1, pp. 28–32, 2000. View at Google Scholar · View at Scopus
  59. E. Crimi, M. Chiaramondia, M. Milanese, G. A. Rossi, and V. Brusasco, “Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen,” American Review of Respiratory Disease, vol. 144, no. 6, pp. 1282–1286, 1991. View at Google Scholar · View at Scopus
  60. G. M. Cauvreau, J. M. Lee, R. M. Watson, A. M. A. Irani, L. B. Schwartz, and P. M. O'Byrne, “Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1473–1478, 2000. View at Google Scholar · View at Scopus
  61. E. B. Mitchell, J. Crow, G. Williams, and T. A. E. Platts-Mills, “Increase in skin mast cells following chronic house dust mite exposure,” British Journal of Dermatology, vol. 114, no. 1, pp. 65–73, 1986. View at Google Scholar · View at Scopus
  62. P. Chanez, J. Y. Lacoste, B. Guillot et al., “Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung,” American Review of Respiratory Disease, vol. 147, no. 6 I, pp. 1497–1502, 1993. View at Google Scholar · View at Scopus
  63. T. Armbrust, D. Batusic, B. Ringe, and G. Ramadori, “Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis,” Journal of Hepatology, vol. 26, no. 5, pp. 1042–1054, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. C. H. Weischer, “Experimental studies on the possibility of influencing mast cells in experimental carrageenin induced rat paw edema; histological study on the effects of some non steroidal anti inflammatory agents (German),” Arzneimittel-Forschung, vol. 26, no. 10, pp. 1867–1870, 1976. View at Google Scholar · View at Scopus
  65. Y. M. Sin, A. D. Sedgwick, E. P. Chea, and D. A. Willoughby, “Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse,” Annals of the Rheumatic Diseases, vol. 45, no. 10, pp. 873–877, 1986. View at Google Scholar · View at Scopus
  66. S. Mazzari, R. Canella, L. Petrelli, G. Marcolongo, and A. Leon, “N-(2-Hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation,” European Journal of Pharmacology, vol. 300, no. 3, pp. 227–236, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. I. Y. Choi, S. J. Kim, H. J. Jeong et al., “Hesperidin inhibits expression of hypoxia inducible factor-1 alpha and inflammatory cytokine production from mast cells,” Molecular and Cellular Biochemistry, vol. 305, no. 1-2, pp. 153–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Hirata, Y. Murakami, M. Shoji, Y. Kadoma, and S. Fujisawa, “Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression,” Anticancer Research, vol. 25, no. 5, pp. 3367–3374, 2005. View at Google Scholar · View at Scopus
  69. M. Jain and H. S. Parmar, “Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation,” Inflammation Research, vol. 60, no. 5, pp. 483–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Li, L. Cai, X. F. Xie, F. Yang, and J. Li, “Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity,” Phytotherapy Research, vol. 24, no. 1, pp. S71–S76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. B. Schröfelbauer, J. Raffetseder, M. Hauner, A. Wolkerstorfer, W. Ernst, and O. H. J. Szolar, “Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling,” The Biochemical Journal, vol. 421, no. 3, pp. 473–482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. S.-W. Kim, Y. Jin, J.-H. Shin et al., “Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion,” Neurobiology of Disease, vol. 46, no. 1, pp. 147–156, 2012. View at Publisher · View at Google Scholar
  73. H. Takei, Y. Baba, A. Hisatsune et al., “Glycyrrhizin inhibits interleukin-8 production and nuclear factor-κB activity in lung epithelial cells, but not through glucocorticoid receptors,” Journal of Pharmacological Sciences, vol. 106, no. 3, pp. 460–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Menegazzi, R. Di Paola, E. Mazzon et al., “Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice,” Pharmacological Research, vol. 58, no. 1, pp. 22–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. J. P. Wang, T. F. Ho, L. C. Chang, and C. C. Chen, “Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice,” Journal of Pharmacy and Pharmacology, vol. 47, no. 10, pp. 857–860, 1995. View at Google Scholar · View at Scopus
  76. J. P. Wang, M. F. Hsu, S. L. Raung, C. C. Chen, J. S. Kuo, and C. M. Teng, “Anti-inflammatory and analgesic effects of magnolol,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 346, no. 6, pp. 707–712, 1992. View at Google Scholar · View at Scopus
  77. A. K. W. Tse, C. K. Wan, G. Y. Zhu et al., “Magnolol suppresses NF-κB activation and NF-κB regulated gene expression through inhibition of IkappaB kinase activation,” Molecular Immunology, vol. 44, no. 10, pp. 2647–2658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Yamauchi, J. Ueda, and K. Ohsawa, “A simultaneous determination of various main components in oriental pharmaceutical decoction “Heii-San” by ion-pair high-performance liquid chromatography,” Yakugaku Zasshi, vol. 116, no. 10, pp. 776–782, 1996. View at Google Scholar · View at Scopus